Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy

Oncogene, Published online: 07 July 2023; doi:10.1038/s41388-023-02760-0Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy
Source: Oncogene - Category: Cancer & Oncology Authors: Source Type: research